CAMBRIDGE, Mass., April 10, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU) today announced the pricing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $7.00 per share, before underwriting discounts. In addition, Cerulean has granted the underwriters a 30-day option to purchase up to an additional 1,275,000 shares of common stock at the public offering price, less underwriting discounts. Cerulean's common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading under the ticker symbol "CERU" today.
Help employers find you! Check out all the jobs and post your resume.
